Lance Berberian

CIK: 0001102900

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (30.0%)

Derivative conversions

Awards (A)3 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PRVA

Privia Health Group, Inc.

Director

LABCORP HOLDINGS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

PRVA
Privia Health Group, Inc.
May 20, 2026
Award(A)
Direct
8.5K shares-
PRVA
Privia Health Group, Inc.
Jul 15, 2025
Award(A)
Direct
7.7K shares-
LH
LABCORP HOLDINGS INC.
Mar 27, 2025
Tax Payment(F)
Direct
1.4K shares at avg. $231.67$313K
LH
LABCORP HOLDINGS INC.
Mar 27, 2025
Award(A)
Direct
3.3K shares-
LH
LABCORP HOLDINGS INC.
Feb 11, 2025
Tax Payment(F)
Direct
86 shares at avg. $245.14$21K
LH
LABCORP HOLDINGS INC.
Feb 11, 2025
Exercise(M)
Direct
323 shares-
LH
LABCORP HOLDINGS INC.
Feb 7, 2025
Exercise(M)
Direct
354 shares-
LH
LABCORP HOLDINGS INC.
Feb 7, 2025
Tax Payment(F)
Direct
94 shares at avg. $246.27$23K
LH
LABCORP HOLDINGS INC.
Feb 6, 2025
Exercise(M)
Direct
356 shares-
LH
LABCORP HOLDINGS INC.
Feb 6, 2025
Tax Payment(F)
Direct
94 shares at avg. $247.74$23K

		Type	Shares	Price		Ownership
May 20, 2026	PRVA Privia Health Group, Inc.	Award(A)	8,463	-	$0	Direct
Jul 15, 2025	PRVA Privia Health Group, Inc.	Award(A)	7,668	-	-	Direct
Mar 27, 2025	LH LABCORP HOLDINGS INC.	Tax Payment(F)	1,353	$231.67	$313,450	Direct
Mar 27, 2025	LH LABCORP HOLDINGS INC.	Award(A)	3,325	-	-	Direct
Feb 11, 2025	LH LABCORP HOLDINGS INC.	Tax Payment(F)	86	$245.14	$21,082	Direct
Feb 11, 2025	LH LABCORP HOLDINGS INC.	Exercise(M)	323	-	-	Direct
Feb 7, 2025	LH LABCORP HOLDINGS INC.	Exercise(M)	354	-	-	Direct
Feb 7, 2025	LH LABCORP HOLDINGS INC.	Tax Payment(F)	94	$246.27	$23,149	Direct
Feb 6, 2025	LH LABCORP HOLDINGS INC.	Exercise(M)	356	-	-	Direct
Feb 6, 2025	LH LABCORP HOLDINGS INC.	Tax Payment(F)	94	$247.74	$23,288	Direct

1-10 of 10 transactions

About BERBERIAN LANCE

BERBERIAN LANCE (SEC CIK 0001102900) files insider reports with the SEC as Director of Privia Health Group, Inc. (PRVA) and EVP, Special Advisor, Strategy of LABCORP HOLDINGS INC. (LH).

Signal8 holds 6 ownership filings by BERBERIAN LANCE (1 Form 3, 5 Form 4), filed between Feb 10, 2025 and May 22, 2026. Those filings report 10 transactions, from Feb 6, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BERBERIAN LANCE's filings is in ARLINGTON, VA.

Recent filings by BERBERIAN LANCE

May 20, 2026: Grant or award of PRVA shares (Form 4, code A).
Jul 15, 2025: Grant or award of PRVA shares (Form 4, code A).
Mar 27, 2025: Tax withholding of LH shares (Form 4, code F).
Mar 27, 2025: Grant or award of LH shares (Form 4, code A).
Feb 11, 2025: Tax withholding of LH shares (Form 4, code F).

Other insiders filing for Privia Health Group, Inc. (PRVA)

Ernest Opella Finley, Director
Mountcastle David, EVP & Chief Financial Officer
Morris Matthew Shawn, Director
SOISTMAN FRANCIS S JR, Director
COCOZZA NANCY G, Director
Kimmet Pamela O, Director

How to read Form 4 transaction codes